It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Department of Surgery and Cancer, Imperial College London, London, UK
2 Division of Cancer Biology, Tumour Microenvironment Team, Institute of Cancer Research, London, UK
3 Department of Surgery and Cancer, Imperial College London, London, UK; MRC Molecular Haematology Unit, Haematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
4 MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Hungarian Academy of Sciences, Budapest, Hungary; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary
5 European Institute of Oncology, Milan, Italy
6 Faculty of Engineering, Department of Bioengineering, Imperial College London, London, UK
7 Department for Life Quality Studies, Alma Mater Studiorum, University of Bologna, Rimini, Italy
8 Department of Chemistry, Imperial College London, London, UK
9 Histopathology Department, Imperial College London, Charing Cross Hospital NHS Trust, London, UK
10 ECMC Imperial College. Department of Surgery and Cancer, Imperial College London, London, UK
11 Pathology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy
12 Division of Cancer Biology, Tumour Microenvironment Team, Institute of Cancer Research, London, UK; Instituto de Biomedicina y Biotecnologia de Cantabria, Santander, Spain